(+)-Epicatechin
N/A
Report date: 2023/12/30 20:00:46
Base Information
Drug Name(+)-Epicatechin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardero Therapeutics IncMayo ClinicUniversity Of California
China Registration ClassN/A
Develop Information
Active CompaniesEpirium Bio Inc
Inactive CompaniesCardero Therapeutics Inc
Active Indications
Inactive Indications